Angion Reports Positive Results from Phase 1 Healthy Volunteer Study for ANG-3070 and FDA Authorization to Initiate Phase 2 Trial in 2021
August 03, 2021 00:05 ET
|
Angion Biomedica Corp.
ANG-3070 was well-tolerated across dose cohorts, achieving drug exposures in humans exceeding exposures in which activity was demonstrated in animal models of proteinuric kidney...
Angion Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
March 30, 2021 16:05 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y., March 30, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Kidney Dialysis Market Value Projected To Reach US$ 96.5 Billion By 2027: Acumen Research And Consulting
March 23, 2021 10:02 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Kidney Dialysis Market – Global Industry Analysis, Market Size, Opportunities and...
Angion to Participate in Upcoming March Investment Conferences
February 24, 2021 00:05 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Renibus Therapeutics Announces Publication of Positive Results of RBT-3 Experimental Preclinical Studies in Scientific Journal Nephrology Dialysis Transplant
February 16, 2021 09:00 ET
|
Rénibus Therapeutics Inc.
-With no currently approved therapies for the prevention or treatment of platinum-induced toxicity, RBT-3 has the potential to fill a critical unmet medical need Dallas, Texas, Feb. 16, 2021 ...
Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 09, 2021 16:10 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization...
Angion Biomedica Corp. Announces Pricing of Initial Public Offering of Common Stock and Concurrent Private Placement
February 05, 2021 08:30 ET
|
Angion Biomedica Corp.
UNIONDALE, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development and commercialization...
Satellite Healthcare Names Industry Veteran Jeffrey Goffman as CEO
December 29, 2020 13:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Satellite Healthcare, the leading nonprofit dialysis provider, today announced Jeffrey Goffman will be its next CEO, effective January 2, 2021....
LogistiCare Donates Vital Funds to National Kidney Foundation Over Six Years
January 16, 2020 10:00 ET
|
LogistiCare
Atlanta, Jan. 16, 2020 (GLOBE NEWSWIRE) -- LogistiCare, the nation’s largest non-emergency medical transportation broker, today announced the organization and thousands of its employees from its...
LogistiCare Team is Number One Fundraiser at Las Vegas Kidney Walk
November 19, 2019 12:00 ET
|
LogistiCare
ATLANTA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- LogistiCare, the nation’s largest non-emergency medical transportation broker, today announced that staff at its Las Vegas Operations Center raised and...